Medicine and Dentistry
Asimadoline
16%
Autonomic Neuropathy
34%
Biological Marker
5%
Bloating
5%
Cardiovascular System
24%
Central Nervous System
22%
Chemokine
7%
Clinical Trial
9%
Colon
13%
Controlled Clinical Trial
22%
Cytokine
40%
Diabetes
100%
Diabetes Mellitus
10%
Diabetic Neuropathy
24%
Dietary Supplement
22%
Enteric Nervous System
22%
Eotaxin
7%
Experimental Diarrhea
5%
Gastrointestinal Disease
18%
Gastrointestinal Distress
72%
Gastrointestinal Motility
12%
Gastrointestinal Transit
33%
Gut
5%
Heart Rate Variability
22%
Insulin Dependent Diabetes Mellitus
35%
Intercellular Adhesion Molecule 1
11%
Interleukin 10
11%
Interleukin 12
22%
Interleukin 6
16%
Interleukin 8
11%
Intestine Innervation
11%
Intestine Motility
8%
Loperamide
16%
Magnetic Resonance Imaging
25%
Maturity Onset Diabetes of the Young
30%
Odds Ratio
11%
Opiate
22%
Opiate Agonist
11%
Patient with Diabetes
8%
Polyneuropathy
22%
Randomized Controlled Trial
27%
Rating Scale
6%
Rescue Therapy
5%
Serositis
9%
Stomach Emptying
16%
Stomach Paresis
28%
Symptom
50%
Tumor Necrosis
16%
Vagus Nerve Stimulation
44%
Vasculotropin C
11%
Keyphrases
Active Groups
6%
Active Stimulation
6%
Anti-inflammatory Strategies
5%
Asimadoline
16%
Autonomic Neuropathy
9%
Cardiovascular Regulation
5%
Clinical Practice
22%
Diabetes Symptoms
22%
Diphenoxylate
5%
Eotaxin
7%
Gastric Emptying Time
7%
Gastrointestinal Diseases
44%
Gastrointestinal Symptom Rating Scale
9%
Gastroparesis Cardinal Symptom Index
9%
General Cognition
6%
Healthy Controls
8%
Intestinal Motility
8%
Magnetic Resonance Imaging
22%
Magnetic Resonance Imaging Scan
8%
Motility
22%
Multicenter Trial
22%
Neurocardiac
11%
Opioid-induced Constipation
22%
Opium Tincture
22%
Patients with Diabetes
31%
Randomized Double-blind
22%
Sham
12%
Sham Control
22%
Sham Stimulation
12%
Small Colon
13%
Small Intestine
22%
Standardised Endpoint
5%
Stomach
8%
Systemic Cytokine
22%
Tight Glucose Control
5%
Transcutaneous Auricular Vagus Nerve Stimulation (taVNS)
22%
Pharmacology, Toxicology and Pharmaceutical Science
Abdominal Pain
11%
Asimadoline
16%
Bloating
5%
Chronic Diarrhea
11%
Clinical Trial
11%
Codeine
5%
Constipation
22%
Diabetic Neuropathy
22%
Diarrhea
22%
Dietary Supplement
22%
Diphenoxylate
5%
Eotaxin
7%
Experimental Diarrhea
5%
Fedotozine
5%
Gastrointestinal Symptom
5%
Interleukin 12
7%
Interleukin 15
7%
Loperamide
16%
Macrophage Derived Chemokine
11%
Nerve Injury
5%
Neuroprotective Agent
5%
Opiate
66%
Opiate Agonist
11%
Placebo
25%
Prospective Study
5%
Randomized Controlled Trial
27%
Tyrosyl Dextro Alanylphenylalanyl Dextro Alanyltyrosinamide
5%